Latest news about CBD, Cannabis and others similar drugs.
People suffering from post-traumatic distress disorder report that cannabis reduces the severity of their symptoms by more than half, at least in the short term, according to a recent study led by Carrie Cuttler,...
Scientists at the University of Basel have shown that LSD reduces activity in the region of the brain related to the handling of negative emotions like fear. The results, published in the scientific journal...
Use marijuana while pregnant, and your child is more likely to suffer sleep problems as much as a decade later, according to a new University of Colorado Boulder study of nearly 12,000 youth. Published...
The altered state of consciousness and temporary lack of ego that results from using psychedelic drugs could help some mental health patients recover from their symptoms, according to academics at the University of Adelaide....
Cannabinoid-containing products may alter the effects of some prescription drugs, according to Penn State College of Medicine researchers. They published information that could help medical professionals make safe prescribing choices for their patients who...
A better understanding of how a key chemical messenger acts in the brain could lead to a radical shift in psychiatric care, according to a new research paper. Serotonin is a neurotransmitter which helps...
Higher rates of e-cigarette and marijuana use in U.S. states did not result in more e-cigarette or vaping-related lung injuries (known as EVALI), a new study from the Yale School of Public Health finds....
A Brazilian study, published in Scientific Reports on October 09, 2017, has identified changes in signaling pathways associated with neural plasticity, inflammation and neurodegeneration triggered by a compound from the family of dimethyltryptamine known...
Scientists have discovered the origin of the characteristic bad smell of cannabis. These are compounds that are also found in garlic with the same potential health benefits.
COMPASS Pathways plc, a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, today announced that its groundbreaking Phase IIb clinical trial of the therapy COMP360 to psilocybin...
